Records 1 - 6
| Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.
International journal of environmental research and public health 2019 Dec 17 (1): .
Yu Ya-Yen, Tsao Shih-Ming, Yang Wen-Ta, Huang Wei-Chang, Lin Ching-Hsiung, Chen Wei-Wen, Yang Shun-Fa, Chiou Hui-Ling, Huang Yi-W
| Effect of antituberculosis treatment on CYP2C19 enzyme activity in genetically polymorphic South Indian Tamilian population.
Fundamental & clinical pharmacology 2016 Jul .
Xavier Alphienes Stanley, Saka Vinod Kumar, Sundaram Rajan, Francis Jose, Deepak Gopal Shewa
| Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.
Clinical and experimental pharmacology & physiology 2013 May 40 (5): 326-32.
Tang Shao-Wen, Lv Xiao-Zhen, Chen Ru, Wu Shan-Shan, Yang Zhi-Rong, Chen Da-Fang, Zhan Si-Y
| Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.
The Indian journal of medical research 2012 May 135 (5): 642-9.
Feng Wei-Xing, Liu Fang, Gu Yi, Jiao Wei-Wei, Sun Lin, Xiao Jing, Wu Xi-Rong, Miao Qing, Shen Chen, Shen Dan, Shen Ado
| NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption.
European journal of clinical pharmacology 2011 Feb 67 (2): 121-7.
Kim Sang-Heon, Kim Sang-Hoon, Yoon Ho Joo, Shin Dong Ho, Park Sung Soo, Kim Youn-Seup, Park Jae-Seuk, Jee Young K
| Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.
Genetic testing and molecular biomarkers 2010 Jun 14 (3): 329-42.
Gra Olga, Mityaeva Olga, Berdichevets Iryna, Kozhekbaeva Zhanna, Fesenko Denis, Kurbatova Olga, Goldenkova-Pavlova Irina, Nasedkina Tatya